Does IPILIMUMAB Cause Immune-mediated nephritis? 91 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 91 reports of Immune-mediated nephritis have been filed in association with IPILIMUMAB (YERVOY). This represents 0.3% of all adverse event reports for IPILIMUMAB.
91
Reports of Immune-mediated nephritis with IPILIMUMAB
0.3%
of all IPILIMUMAB reports
5
Deaths
51
Hospitalizations
How Dangerous Is Immune-mediated nephritis From IPILIMUMAB?
Of the 91 reports, 5 (5.5%) resulted in death, 51 (56.0%) required hospitalization, and 12 (13.2%) were considered life-threatening.
Is Immune-mediated nephritis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 91 reports have been filed with the FAERS database.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Immune-mediated nephritis?
NIVOLUMAB (136)
PEMBROLIZUMAB (128)
CARBOPLATIN (52)
PACLITAXEL (31)
PEMETREXED (25)
DURVALUMAB (17)
ATEZOLIZUMAB (15)
LENVATINIB (11)
CYCLOPHOSPHAMIDE (9)
AXITINIB (8)
Which IPILIMUMAB Alternatives Have Lower Immune-mediated nephritis Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN